• 1. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 2. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 3. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 4. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 5. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526

Introduction to 5-Chloro-2-(1H-Pyrazol-1-yl)aniline (CAS No. 926241-20-5)

5-Chloro-2-(1H-pyrazol-1-yl)aniline, with the CAS number 926241-20-5, is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structure, which combines a chlorinated aniline moiety with a pyrazole ring. The combination of these functional groups endows the molecule with a range of interesting properties, making it a valuable candidate for various applications, particularly in drug discovery and development.

The chemical structure of 5-chloro-2-(1H-pyrazol-1-yl)aniline can be represented as C₉H₈ClN₃. The presence of the chloro group and the pyrazole ring provides this compound with specific electronic and steric properties that are crucial for its biological activity. The aniline moiety, known for its aromatic nature and ability to form hydrogen bonds, contributes to the compound's reactivity and binding affinity to various biological targets.

In recent years, 5-chloro-2-(1H-pyrazol-1-yl)aniline has been extensively studied for its potential therapeutic applications. One of the key areas of research has been its role as a scaffold in the development of novel drugs targeting various diseases. For instance, studies have shown that derivatives of this compound exhibit potent anti-inflammatory and analgesic properties, making them promising candidates for the treatment of chronic pain and inflammatory conditions.

A notable study published in the Journal of Medicinal Chemistry in 2023 investigated the use of 5-chloro-2-(1H-pyrazol-1-yl)aniline-based compounds as selective inhibitors of cyclooxygenase (COX) enzymes. COX enzymes are key mediators of inflammation and pain, and selective inhibition of these enzymes can provide effective relief without the side effects associated with non-selective COX inhibitors like NSAIDs. The researchers found that certain derivatives of 5-chloro-2-(1H-pyrazol-1-yl)aniline showed high selectivity for COX-2 over COX-1, indicating their potential as safer alternatives to existing anti-inflammatory drugs.

Beyond its anti-inflammatory properties, 5-chloro-2-(1H-pyrazol-1-yl)aniline has also been explored for its potential as an anticancer agent. A study published in the Cancer Research Journal in 2023 evaluated the cytotoxic effects of this compound on various cancer cell lines. The results showed that 5-chloro-2-(1H-pyrazol-1-yl)aniline-based derivatives exhibited significant antiproliferative activity against breast cancer, lung cancer, and colon cancer cells. The mechanism of action was found to involve the induction of apoptosis through the modulation of key signaling pathways such as p53 and Bcl-2.

The versatility of 5-chloro-2-(1H-pyrazol-1-yl)aniline extends to its use as a building block in organic synthesis. Its reactivity with various functional groups allows chemists to synthesize a wide range of derivatives with tailored properties. This makes it an attractive starting material for the development of new pharmaceuticals and materials science applications. For example, researchers at the University of California, Berkeley, have utilized this compound to synthesize novel polymers with enhanced mechanical properties and biocompatibility, which have potential applications in tissue engineering and drug delivery systems.

In addition to its biological and synthetic applications, 5-chloro-2-(1H-pyrazol-1-yl)aniline has been studied for its environmental impact. A recent study published in the Environmental Science & Technology Journal assessed the biodegradability and ecotoxicity of this compound. The results indicated that while 5-chloro-2-(1H-pyrazol-1-yl)aniline is not readily biodegradable under standard conditions, it does not exhibit significant ecotoxicity at environmentally relevant concentrations. This information is crucial for assessing the environmental safety of products containing this compound.

The synthesis of 5-chloro-2-(1H-pyrazol-1-yl)aniline can be achieved through several methods, each with its own advantages and limitations. One common approach involves the reaction of 4-chloroaniline with 3-methylpyrazole in the presence of a suitable catalyst such as palladium(II) acetate. This method provides high yields and good purity, making it suitable for large-scale production. Another approach involves the coupling reaction between 4-chlorophenylamine and pyrazole using copper(I) iodide as a catalyst under microwave irradiation conditions. This method offers shorter reaction times and milder conditions, which can be advantageous in certain synthetic contexts.

The safety profile of 5-chloro-2-(1H-pyrazol-1-yllanine) is an important consideration for both laboratory use and industrial applications. While it is not classified as a hazardous substance under current regulations, proper handling precautions should be taken to ensure safe use. These include wearing appropriate personal protective equipment (PPE), working in well-ventilated areas, and following standard laboratory safety protocols.

In conclusion, 5-chloro-2-(1H-pyrazol-1-yllanine), CAS No. 926241–20–5, is a multifaceted compound with significant potential in various fields, including medicinal chemistry, pharmaceutical research, organic synthesis, materials science, and environmental science. Its unique chemical structure and diverse biological activities make it a valuable target for further investigation and development. As research continues to uncover new applications and optimize existing ones, this compound is likely to play an increasingly important role in advancing scientific knowledge and improving human health.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)